ADC is known as precision therapy, which delivers drugs precisely to tumor cells through targeted antibodies, maximizing the destruction of tumors while minimizing damage to normal tissues. In the design of ADC, antibodies are responsible for “navigation,” while the payload (toxin) is the true “terminator.” This article will discuss the classification of mainstream ADC payloads, why topoisomerase I inhibitors have gained popularity, and DAR (…